Medindia

X

Emperra Wins Prestigious Award With Innovative Diabetes Device

Thursday, November 24, 2016 Diabetes News J E 4
Advertisement

LONDON, November 24, 2016 /PRNewswire/ --

Emperra GmbH E-Health Technologies was announced Business Worldwide Magazine's (BWM) 2016 Company of the Year Award/Medical Device Industry Europe for its innovative diabetes management system.

     (Photo: http://photos.prnewswire.com/prnh/20161123/442551 )

The device, known as ESYSTA® combines modern hardware (a blood glucose meter and insulin pen) with intelligent software in order to allow data to transfer automatically from patient to doctor (such as blood glucose readings, insulin dosage and carbohydrate intake). The doctor can then gain access to the information online and advise on any necessary alterations with the result that the patient's diabetes management is considerably improved.

The ESYSTA® system has already proven successful in Germany where it was first launched and now the company are eagerly awaiting approval from the Food and Drug Agency (FDA) in order to bring it to US markets next year.

Emperra CEO Christian Krey thanked the BWM judges for choosing his company as winner of the award.

He added: "We are delighted to be recognised in this way and hope it is an indication of how others in the global medical and business community will see our ESYSTA® system."

Krey believes Emperra's success is down to the fact that their product provides an all-encompassing solution to diabetes control in that it considers an individual's lifestyle and capability, as well as their illness.

He added: "Most companies only come up with part of the solution, such as blood glucose readings, software solutions, or coaching. Currently there's no smart insulin pen on the market that can be downloaded wirelessly to get important information about insulin dosing. And that's where we come in, by offering the whole range of therapy information, the type which would normally be collected by the patient themselves. "

Krey went on to state that surveys show up to 60 per cent of individuals with diabetes fail to reach their glucose targets, and poor monitoring is one reason. This leads to secondary complications which in turn affect the patient's quality of life and prove a cost burden on society in terms of health care.

A spokesman for BWM said the panel were impressed with the imaginative system itself and the energy of the team behind the company. They were also aware of the certain improvements that the device would bring to the daily lives of millions of diabetes sufferers around the globe.

"Emperra GmbH E-Health Technologies were outright winners of our Company of the Year Award for the Medical Device Industry" he said. "We hope that this accolade and the company's achievements to date will go on to inspire others in a similar position within the same field."

More information on the ESYSTA system and the work of Emperra GmbH E-Health Technologies can be found at the website http://www.emperra.com

An article on the company can also be found on BWM website

http://www.bwmonline.com/2016/08/21/emperra-leading-way-telemedicine-based-product-systems-diabetes-care/

For more details on Business Worldwide Magazine Awards 2016, go to http://www.bwmonline.com/awards/ About Business Worldwide Magazine Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world. Our quarterly magazine and online news portal enables an established audience of corporate dealmakers to track the latest news, stories and developments affecting the international markets, corporate finance, business strategy and changes in legislation. This readership includes of CEO/CFO - Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few.

http://www.bwmonline.com

Contact David Jones Awards Department E: david.jones@bwmonline.com W: http://www.bwmonline.com

SOURCE Business Worldwide Magazine

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Clarity Benefit Solutions Lists Seven Benefits of ...
S
Kymab Secures US$100 Million Series C Funding